Clinical Trial Update: The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The "INRange" RCT [Phase 4]

View source ↗

Summary

The INRange Phase 4 trial evaluated whether timing of warfarin dosing affects anticoagulation stability in patients with atrial fibrillation or prosthetic heart…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Deep Vein Thrombosis
• Prosthetic Heart Valve Thrombosis
• Venous Thromboembolism

Drugs mentioned

• Warfarin (warfarin)

Snippet

Sponsor: University of Alberta | Conditions: Atrial Fibrillation, Thrombus Due to Heart Valve Prosthesis | Phase 4 | Status: COMPLETED